Michael Berelowitz

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

14 documents for Michael Berelowitz

- Dr. Yvonne Greenstreet Joins Pfizer As Senior Vice President And Head Of Medicines Development, Specialty Care Business Unit.
...Dr. Greenstreet takes over for Dr. Michael Berelowitz, who is retiring after a distinguished ...
- Business Wire
- January 31, 2011
- Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contracture.
... therefore impacts quality of life," said Michael Berelowitz, M.D., senior vice president, Clinical ...
- Business Wire
- January 21, 2010
- Pfizer Moves to Protect Lipitor From Cheaper Drug
By Stephanie Saul and Alex Berenson The New York Times

...Michael Berelowitz, senior vice president for worldwide me...
- The Virginian-Pilot and The Ledger-Star, Norfolk, VA
- November 03, 2007

- CP-690,550, Pfizer's Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis.
... patients with rheumatoid arthritis," said Michael Berelowitz, MD, senior vice president Clinical Dev...
- Business Wire
- October 17, 2009
- Pfizer's Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response For Patients with Rheumatoid Arthritis, New Phase 2 Studies Show.
... to currently available therapies," said Michael Berelowitz, MD, Senior Vice President Clinical Dev...
- Business Wire
- June 11, 2009
- Patients Treated with Lipitor Were Significantly Less Likely to Have a Cardiovascular Event Than Those Treated with Simvastatin, New Observational Study Shows.
...According to Dr. Michael Berelowitz, senior vice president of Pfizer's glob...
- Business Wire
- January 14, 2008
- Pfizer to Present New Lipitor Data, Including Results from Three Large Atherosclerosis Imaging Trials, at the American College of Cardiology Meeting.
...Michael Berelowitz, senior vice president of Pfizer's glob...
- Business Wire
- March 23, 2007
- Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show.
...Michael Berelowitz, senior vice president of Pfizer's glob...
- Business Wire
- March 27, 2007
- Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care.
... the best care to patients," said Michael Berelowitz, MD, Senior Vice President of Global Me...
- Business Wire
- October 15, 2007
- Patients Who Switched from Established Lipitor Therapy to Simvastatin Experienced a Significant 30 Percent Increase in Relative Risk of Cardiovascular Events or Death, New Observational Study Shows.
...Michael Berelowitz, senior vice president of Pfizer's glob...
- Business Wire
- September 05, 2007